Pharmacy- Page 6

Roche ranked the most sustainable healthcare company in the DJSI

November 16, 2020

Pharmacy

The FINANCIAL — For the eleventh time, Roche has been recognised as the most sustainable company in the Pharmaceuticals index of the Dow Jones Sustainability Indices (DJSI). This is based on an in-depth analysis of economic, social and environmental performance. The DJSI family of indices serves as a benchmark for investors who integrate sustainability considerations into their portfolios. Roche has

Gilead and Novo Nordisk announced new data from proof-of-concept trial in NASH

The FINANCIAL — Gilead Sciences, Inc. and Novo Nordisk A/S announced results

by The FINANCIAL

November 16, 2020

2 mins read

Metagenomi closes USD 65 million Series A financing led by Leaps by Bayer and Humboldt Fund

The FINANCIAL — Metagenomi, a next generation gene editing company launched by

by The FINANCIAL

November 12, 2020

1 min read

Pharmaceutical industries join to promise fair access to COVID-19 medicines and vaccines

The FINANCIAL — On the occasion of the World Health Assembly, the world’s

by The FINANCIAL

November 12, 2020

1 min read

Pharmacy

Abbott Labs’ quarterly revenue rises 16.7 percent

The FINANCIAL -- Abbott on April 18 announced financial results for the first quarter ended March 31, 2018.

by The FINANCIAL

April 18, 2018

5 mins read

Pharmacy

Johnson & Johnson Raises Sales Outlook

The FINANCIAL -- Johnson & Johnson on April 17 announced sales of $20.0 billion for the first quarter of 2018, an increase of 12.6% as compared to the first quarter of 2017.

by The FINANCIAL

April 18, 2018

4 mins read

Pharmacy

GSK and Orchard Therapeutics announced a strategic agreement

The FINANCIAL -- GSK and Orchard Therapeutics on April 12 announced a strategic agreement, under which GSK will transfer its portfolio of approved and investigational rare disease gene therapies to Orchard, securing the continued development of the programmes and access for patients.

by The FINANCIAL

April 13, 2018

3 mins read

Pharmacy

Sanofi to invest €350 million in Canadian vaccine facility

The FINANCIAL -- Sanofi is investing €350 million (CAD $500 million) for the construction of a new state-of-the-art vaccine manufacturing facility at the Sanofi Pasteur Canadian headquarters in Toronto, Ontario.

by The FINANCIAL

April 12, 2018

1 min read

Pharmacy

Novartis reports positive new heart failure data for Entresto

The FINANCIAL -- Novartis on April 4 announced that JAMA Cardiology has published results from a post-hoc analysis demonstrating that treatment with Entresto (sacubitril/valsartan) significantly improved seven out of 10 types of physical and social activities at eight months in heart failure

by The FINANCIAL

April 5, 2018

2 mins read

Pharmacy

Eli Lilly: CYRAMZA Phase 3 REACH-2 Study Meets Primary Endpoint

The FINANCIAL -- Eli Lilly and Company on April 4 announced top-line results from its Phase 3 REACH-2 study of CYRAMZA (ramucirumab) as a single agent in the second-line treatment of people with hepatocellular carcinoma (HCC), also known as liver cancer.

by The FINANCIAL

April 4, 2018

2 mins read

Pharmacy

European Commission Approves Expanded Indication For Amgen’s XGEVA

The FINANCIAL -- Amgen on April 2 announced that the European Commission (EC) has approved an expanded indication for XGEVA (denosumab) for the prevention of skeletal-related events in adults with advanced malignancies involving bone.

by The FINANCIAL

April 3, 2018

1 min read

Pharmacy

EMA to review Dupixent as potential treatment for inadequately controlled moderate-to-severe asthma

The FINANCIAL -- The European Medicines Agency (EMA) has accepted for review an application for Dupixent (dupilumab) as an add-on maintenance treatment in certain adults and adolescents (12 years of age and older) with inadequately controlled moderate-to-severe asthma.

by The FINANCIAL

April 3, 2018

1 min read

Pharmacy

FDA Approves BLINCYTO

The FINANCIAL -- Amgen on March 29 announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for BLINCYTO (blinatumomab) for the treatment of adults and children with B-cell precursor acute lymphoblastic leukemia (ALL) in

by The FINANCIAL

March 30, 2018

1 min read

Pharmacy

Novartis to sell stake in consumer healthcare joint venture to GSK for USD13.0 billion to focus on strategic priorities

The FINANCIAL -- Novartis announced on March 27 that it has entered into an agreement with GlaxoSmithKline plc (GSK) to divest its 36.5 percent stake in its consumer healthcare joint venture (JV) to GSK for USD13.0 billion.

by The FINANCIAL

March 27, 2018

1 min read